Work

Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects

Year: 2016

Type: article

Study design: Clinical Trial

Source: Journal of Antimicrobial Chemotherapy

DOI: 10.1093/jac/dkw458

Authors: Didier Scherrer, Regine Rouzier, P. Noel Barrett, Jean-Marc Steens, Paul Gineste, Robert L. Murphy, Jamal Tazi, Hartmut J. Ehrlich

Institutions: Abivax (France), Northwestern University, Université de Montpellier, Institut de Génétique Moléculaire de Montpellier

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2566615259

FWCI: 2.771

Cites: 30

Cited by: 20

Related to: 10